Huakang
8622.HKHuakang Biomedical Holdings Company Limited Price (8622.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
415,962,411
(2.7984)%Cash Flow Statement
Huakang Biomedical Holdings Company LimitedCurrency: HKD
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | 9.20M
+0% |
9.94M
+8% |
-247,000.00
-102% |
1.24M
-603% |
658.00k
-47% |
-11,372,000.00
-1,828% |
-3,903,000.00
-66% |
-3,007,000.00
-23% |
-5,782,000.00
+92% |
||||||||||
| Depreciation And Amortiz... | 511.00k | 908.00k | 1.42M | 1.69M | 2.76M | 3.19M | 2.95M | 3.14M | 3.18M | ||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.55M | 0.00 | 0.00 | 0.00 | ||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.66M | 0.00 | 0.00 | 0.00 | ||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -2,252,000.00 | -2,161,000.00 | -856,000.00 | -2,255,000.00 | 879.00k | -211,000.00 | -533,000.00 | -444,000.00 | -1,627,000.00 | ||||||||||
| Accounts Payables | 0.00 | 0.00 | 0.00 | 0.00 | -879,000.00 | 211.00k | 533.00k | 444.00k | 0.00 | ||||||||||
| Inventory | -329,000.00 | -27,000.00 | 463.00k | -339,000.00 | -419,000.00 | -63,000.00 | -1,634,000.00 | 1.05M | -489,000.00 | ||||||||||
| Other Working Capital | -2,581,000.00 | -245,000.00 | 3.13M | -1,172,000.00 | -4,174,000.00 | -728,000.00 | 148.00k | 524.00k | 3.77M | ||||||||||
| Other Non-Cash Items | -1,349,000.00 | 675.00k | -2,072,000.00 | -471,000.00 | -2,217,000.00 | -167,000.00 | 62.00k | -419,000.00 | 899.00k | ||||||||||
| Net Cash Provided By Op... | 5.46M
+0% |
11.26M
+106% |
2.70M
-76% |
951.00k
-65% |
-3,390,000.00
-456% |
-3,924,000.00
+16% |
-2,378,000.00
-39% |
1.29M
-154% |
-48,000.00
-104% |
||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -4,344,000.00 | -2,643,000.00 | -5,473,000.00 | -2,851,000.00 | -2,208,000.00 | -2,081,000.00 | -2,331,000.00 | -811,000.00 | -1,502,000.00 | ||||||||||
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -40,000.00 | 0.00 | -1,900,000.00 | 0.00 | ||||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Other Investing Activities | 10.59M | 1.07M | 1.09M | 394.00k | 184.00k | 185.00k | 276.00k | -3,398,000.00 | 349.00k | ||||||||||
| Net Cash Used For Inv... | 6.25M
+0% |
-1,569,000.00
-125% |
-4,380,000.00
+179% |
-2,457,000.00
-44% |
-2,024,000.00
-18% |
-1,936,000.00
-4% |
-2,055,000.00
+6% |
-6,109,000.00
+197% |
-1,153,000.00
-81% |
||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | -9,100,000.00 | -600,000.00 | -950,000.00 | 0.00 | 0.00 | 0.00 | -1,467,000.00 | 0.00 | 0.00 | ||||||||||
| Common Stock Issued | 0.00 | 0.00 | 16.67M | 43.86M | 0.00 | 0.00 | 0.00 | 2.31M | 467.00k | ||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Other Financing Activities | -31,000.00 | 735.00k | -10,139,000.00 | -7,368,000.00 | -594,000.00 | -1,107,000.00 | 101.00k | 19.00k | 556.00k | ||||||||||
| Net Cash Used/Provide... | -9,131,000.00
+0% |
135.00k
-101% |
5.58M
+4,032% |
36.49M
+554% |
-594,000.00
-102% |
-1,107,000.00
+86% |
-1,366,000.00
+23% |
2.32M
-270% |
1.02M
-56% |
||||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 0.00 | 0.00 | 4.00k | 118.00k | 62.00k | -405,000.00 | -190,000.00 | ||||||||||
| Net Change In Cash | 2.57M | 9.82M | 3.90M | 34.99M | -6,004,000.00 | -6,849,000.00 | -5,737,000.00 | -2,904,000.00 | -368,000.00 | ||||||||||
| Cash At Beginning Of Per... | 3.52M | 6.09M | 15.91M | 19.81M | 54.80M | 48.79M | 41.94M | 36.21M | 33.30M | ||||||||||
| Cash At End Of Period | 6.09M | 15.91M | 19.81M | 54.80M | 48.79M | 41.94M | 36.21M | 33.30M | 32.94M | ||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 5.46M | 11.26M | 2.70M | 951.00k | -3,390,000.00 | -3,924,000.00 | -2,378,000.00 | 1.29M | -48,000.00 | ||||||||||
| Capital Expenditure | -4,344,000.00 | -2,643,000.00 | -5,473,000.00 | -2,851,000.00 | -2,208,000.00 | -2,081,000.00 | -2,331,000.00 | -811,000.00 | -1,502,000.00 | ||||||||||
| Free Cash Flow | 1.11M
+0% |
8.61M
+675% |
-2,774,000.00
-132% |
-1,900,000.00
-32% |
-5,598,000.00
+195% |
-6,005,000.00
+7% |
-4,709,000.00
-22% |
475.00k
-110% |
-1,550,000.00
-426% |
||||||||||